ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 2.69X leverage
OneSource Specialty Pharma live price: ₹1473.6. It opened at ₹1,452 vs previous close ₹1,474; intraday high/low: ₹1,496/₹1,452. The 50 & 200 DMA stand at ₹1,421.64/₹1,607.95.
OneSource Specialty Pharma Performance
- Low
- ₹1,452
- High
- ₹1,496
- 52 Week Low
- ₹1,057
- 52 Week High
- ₹2,248
- Open Price₹1,452
- Previous Close₹1,474
- Volume73,378
- 50 DMA₹1,421.64
- 100 DMA₹1,528.30
- 200 DMA₹1,607.95
Investment Returns
- Over 1 Month + 23.5%
- Over 3 Month -12.93%
- Over 6 Month -20%
- Over 1 Year + 1.03%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 840.2
- PEG Ratio
- 7.4
- Market Cap Cr
- 16,891
- P/B Ratio
- 2.9
- Average True Range
- 81.31
- EPS
- 2.67
- Dividend Yield
- 0
- MACD Signal
- -2.78
- RSI
- 60.52
- MFI
- 65.79
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,473.60
-0.3
(-0.02%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹1,362.41
- 50 Day
- ₹1,419.52
- 100 Day
- ₹1,529.40
- 200 Day
- ₹1,609.30
Resistance and Support
1485.43
- R3 1,615.87
- R2 1,576.23
- R1 1,525.07
- S1 1,434.27
- S2 1,394.63
- S3 1,343.47
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,473 As on 11 March, 2026 | 18:51
The Market Cap of OneSource Specialty Pharma is ₹16890.6 Cr As on 11 March, 2026 | 18:51
The P/E ratio of OneSource Specialty Pharma is 840.2 As on 11 March, 2026 | 18:51
The PB ratio of OneSource Specialty Pharma is 2.9 As on 11 March, 2026 | 18:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.